Building the Commercial Architecture
Behind Healthcare Growth.
Blueprint Advisory Dx™ is built for healthcare companies at critical growth stages – where commercial decisions carry the most weight and the cost of getting them wrong is highest. We work best with teams that need senior commercial thinking applied directly to the problem in front of them.
Senior-level commercialization expertise for diagnostics, medtech, biotech, and life science companies – applied exactly where and when it matters most.
Most commercial challenges in healthcare don't fail for lack of ideas. They fail because execution is disconnected from strategy, and strategy is disconnected from the market.
Blueprint Advisory Dx™ closes that gap with senior-level commercialization experience across strategy, market access, insights, operations, and partnerships – the rigor to turn direction into results. Built for inflection points: fundraising, launch, partnership development, scale, and exit preparation. Expert horsepower, without the full-time overhead.
Deep Healthcare Expertise
Commercialization experience across strategy, market access, insights, operations, and partnerships, built specifically for healthcare and life sciences.
Executive-Level Thinking
Senior thinking paired with practical execution planning. No generic consulting language, no frameworks for their own sake.
Flexible Engagement
Expert horsepower without full-time overhead. Support scales up or down as your company evolves.
Built by an operator, not just an advisor.
Blueprint Advisory Dx™ was founded by a commercial executive with more than 30 years of experience building markets, launching technologies, and leading commercial organizations across diagnostics, biotechnology, oncology, and precision medicine. That experience spans early-stage startups to global industry leaders, with a track record of translating complex science into commercial strategy, credible market positioning, and sustainable business growth. Blueprint Advisory Dx exists to bring that same operator-level thinking to companies navigating their own critical growth stages.
The commercialization gap is often what separates promising science from fundable growth.
Healthcare companies face a consistent pattern: strong science, underdeveloped commercial foundation – and the pressure to answer harder questions from investors, payers, and partners
arrives faster than most teams anticipate. Companies Need to Show:
A Clear Target Market
and the most realistic entry point.
Differentiation
with a value story for customers, payers and partners.
Evidence, Reimbursement & Adoption
with a practical route to each.
A Growth Model
that links strategy, execution and enterprise value.
Companies that build this earlier are easier to back, easier to partner with, and more credible in the market.
Blueprint Advisory Dx works with healthcare companies at critical growth stages – where commercial decisions carry the most weight and the cost of getting them wrong is highest.
Let’s begin the conversation.
Not sure where to start? We're here to help. Every company's commercial path is different, and we want to make sure our approach fits yours. Reach out with any questions, or if you're ready to dive in, schedule a call today.